Freshworks (FRSH) 10-Q 4 May 23 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	Apr. 28, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-40806
Entity Registrant Name	Freshworks Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2950 S Delaware Street
Entity Address, Address Line Two	Suite 201
Entity Address, City or Town	San Mateo
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94403
Entity Tax Identification Number	33-1218825
City Area Code	650
Local Phone Number	513-0514
Title of 12(b) Security	Class A common stock, par value $0.00001 per share
Trading Symbol	FRSH
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001544522
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		168,032,444
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		123,110,145

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 344,487	$ 304,083
Marketable securities	806,122	843,405
Accounts receivable, net of allowance of $7,288 and $6,628	72,807	70,470
Deferred contract acquisition costs	20,761	20,139
Prepaid expenses and other current assets	46,487	38,913
Total current assets	1,290,664	1,277,010
Property and equipment, net	24,214	24,139
Operating lease right-of-use assets	31,175	33,024
Deferred contract acquisition costs, noncurrent	18,865	19,536
Goodwill	6,181	6,181
Deferred tax assets	8,645	8,689
Other assets	11,098	11,637
Total assets	1,390,842	1,380,216
Current liabilities:
Accounts payable	4,415	5,908
Accrued liabilities	58,327	59,008
Deferred revenue	220,550	205,626
Income tax payable	2,177	1,150
Total current liabilities	285,469	271,692
Operating lease liabilities, non-current	26,183	28,174
Other liabilities	28,748	28,532
Total liabilities	340,400	328,398
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred Stock, value	0	0
Additional paid-in capital	4,600,688	4,562,319
Accumulated other comprehensive loss	(4,512)	(7,431)
Accumulated deficit	(3,545,737)	(3,503,073)
Total stockholders' equity	1,050,442	1,051,818
Total liabilities and stockholders' equity	1,390,842	1,380,216
Class A Common Stock
Stockholders' equity:
Common stock, value	2	2
Class B Common Stock
Stockholders' equity:
Common stock, value	$ 1	$ 1

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Accounts receivable, allowance for credit loss, current	$ 7,288	$ 6,628
Preferred stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	167,518,238	162,825,075
Common stock, outstanding (in shares)	167,518,238	162,825,075
Class B Common Stock
Common stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	350,000,000	350,000,000
Common stock, issued (in shares)	123,016,745	126,268,150
Common stock, outstanding (in shares)	123,016,745	126,268,150

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue	$ 137,692	$ 114,637
Cost of revenue	25,236	22,395
Gross profit	112,456	92,242
Operating expense:
Research and development	32,857	30,717
Sales and marketing	86,810	71,466
General and administrative	40,896	37,183
Total operating expenses	160,563	139,366
Loss from operations	(48,107)	(47,124)
Interest and other income, net	9,479	602
Loss before income taxes	(38,628)	(46,522)
Provision for income taxes	4,036	2,537
Net loss	$ (42,664)	$ (49,059)
Net loss per share - basic (in dollars per share)	$ (0.15)	$ (0.18)
Net loss per share - diluted (in dollars per share)	$ (0.15)	$ (0.18)
Weighted-average shares used in computing net loss per share - basic (in shares)	290,133	278,186
Weighted-average shares used in computing net loss per share - diluted (in shares)	290,133	278,186

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (42,664)	$ (49,059)
Other comprehensive loss:
Change in unrealized loss on marketable securities	2,922	(3,606)
Net change on cash flow hedges	(3)	0
Total other comprehensive income (loss)	2,919	(3,606)
Comprehensive loss	$ (39,745)	$ (52,665)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		273,294
Beginning balance at Dec. 31, 2021	$ 1,238,039	$ 3	$ 4,509,724	$ (747)	$ (3,270,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		113
Issuance of common stock upon exercise of stock options	29		29
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		9,663
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	(120,810)		(120,810)
Stock-based compensation	46,625		46,625
Other comprehensive income	(3,606)			(3,606)
Net loss	(49,059)				(49,059)
Ending balance (in shares) at Mar. 31, 2022		283,070
Ending balance at Mar. 31, 2022	1,111,218	$ 3	4,435,568	(4,353)	(3,320,000)
Beginning balance (in shares) at Dec. 31, 2022		289,093
Beginning balance at Dec. 31, 2022	$ 1,051,818	$ 3	4,562,319	(7,431)	(3,503,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	19	19
Issuance of common stock upon exercise of stock options	$ 6		6
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		1,423
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	(12,845)		(12,845)
Stock-based compensation	51,208		51,208
Other comprehensive income	2,919			2,919
Net loss	(42,664)				(42,664)
Ending balance (in shares) at Mar. 31, 2023		290,535
Ending balance at Mar. 31, 2023	$ 1,050,442	$ 3	$ 4,600,688	$ (4,512)	$ (3,545,737)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (42,664)	$ (49,059)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	3,112	2,973
Amortization of deferred contract acquisition costs	5,617	4,275
Non-cash lease expense	1,850	1,404
Stock-based compensation	50,694	46,625
Premium (discount) amortization on marketable securities	(3,520)	766
Change in fair value of equity securities	(15)	(85)
Deferred income taxes	113	309
Other	85	754
Changes in operating assets and liabilities:
Accounts receivable	(2,490)	3,160
Deferred contract acquisition costs	(5,568)	(5,600)
Prepaid expenses and other assets	(7,248)	(8,685)
Accounts payable	(1,494)	(2,059)
Accrued and other liabilities	(392)	(4,972)
Deferred revenue	14,924	14,239
Operating lease liabilities	(1,500)	(2,690)
Net cash provided by operating activities	11,504	1,355
Cash Flows from Investing Activities:
Purchases of property and equipment	(383)	(1,397)
Proceeds from sale of property and equipment	24	17
Capitalized internal-use software	(2,025)	(1,344)
Purchases of marketable securities	(217,754)	(151,408)
Sales of marketable securities	0	58,736
Maturities and redemptions of marketable securities	261,474	69,750
Net cash provided by (used in) investing activities	41,336	(25,646)
Cash Flows from Financing Activities:
Proceeds from exercise of stock options	6	28
Payment of withholding taxes on net share settlement of equity awards	(12,434)	(119,948)
Payment of deferred offering costs	0	(109)
Net cash used in financing activities	(12,428)	(120,029)
Net increase (decrease) in cash, cash equivalents and restricted cash	40,412	(144,320)
Cash, cash equivalents and restricted cash, beginning of period	304,158	747,864
Cash, cash equivalents and restricted cash, end of period	344,570	603,544
Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets:
Cash and cash equivalents	344,487	603,466
Restricted cash included in prepaid expenses and other current assets	3	46
Restricted cash included in other assets	80	32
Total cash, cash equivalents and restricted cash	344,570	603,544
Supplemental cash flow information:
Cash paid for taxes	2,158	3,649
Non-cash investing and financing activities:
Operating lease right-of-use assets obtained in exchange for operating lease obligations	0	5,324
Stock-based compensation capitalized as internal-use software	$ 514	$ 0

Business, Basis of Presentation

Business, Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business, Basis of Presentation and Summary of Significant Accounting Policies	1. Business, Basis of Presentation and Summary of Significant Accounting Policies Description of Business Freshworks Inc. (Freshworks, or the Company) is a software development company that provides modern software-as-a-service (SaaS) products that are designed with the user in mind. The Company was incorporated in Delaware in 2010 and is headquartered in San Mateo, California. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation. Unaudited Interim Consolidated Financial Statement s The accompanying condensed consolidated balance sheet as of March 31, 2023, the condensed consolidated statements of operations, of comprehensive loss, of cash flows, and of stockholders’ equity for the three months ended March 31, 2023 and 2022, and the related notes to such condensed consolidated financial statements are unaudited. These unaudited condensed consolidated financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2023 and its results of operations and cash flows for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 23, 2023. Use of Estimates The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of acquired intangible assets and goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases. Concentrations of Risk Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash, cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the three months ended March 31, 2023 and 2022 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of March 31, 2023. The Company primarily relies upon its third-party cloud infrastructure partner, Amazon Web Services, to serve customers and operate certain aspects of its services. Any disruption of this cloud infrastructure partner would impact the Company's operations and its business could be adversely impacted. Significant Accounting Policies The Company's significant accounting policies are described in the Annual Report on Form 10-K for the year ended December 31, 2022. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and the related notes for the three months ended March 31, 2023. However, starting in 2023, the Company entered into foreign exchange forward contracts to hedge a portion of its forecasted foreign currency expenses and while the impact of the Company's derivative instruments are not material to its condensed consolidated financial statements, the accounting policy on Derivative Instruments is discussed below. Derivative Instruments The Company enters into foreign currency forward contracts, most of which were designated as cash flow hedges, in order to manage the volatility of cash flows that relate to cost of revenues and operating expenses denominated in Indian Rupee. All derivative instruments are measured at fair value based upon quoted market prices for comparable instruments and as such, classified within Level 2 of the fair value hierarchy. Derivative assets and liabilities are presented on a gross basis on the condensed consolidated balance sheets under prepaid expenses and other current assets and accrued liabilities, respectively. Gains or losses related to cash flow hedges are recorded as a component of accumulated other comprehensive income (AOCI) on the condensed consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within interest and other income. Changes in the fair value of currency forward exchange contracts due to changes in time value were excluded from the assessment of effectiveness. The initial value of this excluded component is amortized on a straight-line basis over the life of the hedging instrument and recognized in the f inancial statement line item to which the hedge relates. A majority of the balance related to foreign exchange derivative instruments included in AOCI at March 31, 2023 is expected to be reclassified into earnings within 12 months. Derivative instruments are classified in the condensed consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions. The Company does not use derivative financial instruments for trading or speculative purposes. As of March 31, 2023, the total notional amount of outstanding designated foreign currency forward contracts was $22.3 million. The fair value of derivative assets and liabilities as of March 31, 2023, and all related unrealized and realized gains and losses during the three months ended March 31, 2023 were not material. Entering into derivative instruments exposes the Company to credit risk to the extent that the counterparties are unable to meet the terms of the contract. The Company mitigates this credit risk by transacting with major financial institutions with high credit ratings. In addition, the Company has entered into master netting arrangements that mitigates credit risk by permitting net settlement of transactions. As such, the Company's exposure is not considered significant. The Company does not have any collateral requirements with its counterparties. Recent Accounting Pronouncements There have been no recently issued accounting pronouncements that are expected to have a material impact on the Company's condensed consolidated financial statements.

Revenue From Contracts with Cus

Revenue From Contracts with Customers	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue From Contracts with Customers	2. Revenue From Contracts with Customers The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes. Disaggregation of Revenue The following table summarizes revenue by the Company’s service offerings (in thousands): Three Months Ended March 31, 2023 2022 Subscription services $ 134,023 $ 111,397 Professional services 3,669 3,240 Total revenue $ 137,692 $ 114,637 See Note 11 for revenue by geographic location. Deferred Revenue and Remaining Performance Obligations Deferred revenue consists of customer billings in advance of revenue being recognized from the Company’s subscription and professional services arrangements. Revenue recognized during the three months ended March 31, 2023 and 2022 from amounts included in deferred revenue at the beginning of these periods was $93.7 million and $72.2 million, respectively. The aggregate balance of remaining performance obligations as of March 31, 2023 was $325.6 million. The Company expects to recognize $253.7 million of the balance as revenue in the next 12 months and the remainder thereafter. The aggregate balance of remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and unbilled amounts that will be recognized as revenue in future periods. Deferred Contract Acquisition Costs The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Three Months Ended March 31, 2023 2022 Balance at beginning of the period $ 39,675 $ 29,647 Add: Contract costs capitalized during the period 5,568 5,600 Less: Amortization of contract costs during the period (5,617) (4,275) Balance at end of the period $ 39,626 $ 30,972

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	3. Cash Equivalents and Marketable Securities Cash equivalents and available-for-sale debt securities consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 155,266 $ — $ — $ 155,266 U.S. treasury securities 37,797 9 — 37,806 U.S. government agency securities 48,796 18 — 48,814 Corporate debt securities 10,474 — — 10,474 Total cash equivalents 252,333 27 — 252,360 Debt securities: U.S. treasury securities 346,566 95 (1,621) 345,040 U.S. government agency securities 376,006 232 (2,691) 373,547 Corporate debt securities 86,564 — (550) 86,014 Total debt securities 809,136 327 (4,862) 804,601 Total cash equivalents and debt securities $ 1,061,469 $ 354 $ (4,862) $ 1,056,961 December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 219,512 $ — $ — $ 219,512 U.S. treasury securities 13,912 3 — 13,915 U.S. government agency securities 10,417 2 — 10,419 Corporate debt securities 1,995 1 — 1,996 Total cash equivalents 245,836 6 — 245,842 Debt securities: U.S. treasury securities 441,909 36 (3,160) 438,785 U.S. government agency securities 301,009 35 (3,531) 297,513 Corporate debt securities 106,436 — (817) 105,619 Total debt securities 849,354 71 (7,508) 841,917 Total cash equivalents and debt securities $ 1,095,190 $ 77 $ (7,508) $ 1,087,759 The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 89,652 $ (687) $ 76,712 $ (934) $ 166,364 $ (1,621) U.S. government agency securities 241,211 (1,701) 39,039 (990) 280,250 (2,691) Corporate debt securities 20,555 (275) 20,596 (275) 41,151 (550) Total $ 351,418 $ (2,663) $ 136,347 $ (2,199) $ 487,765 $ (4,862) December 31, 2022 Less Than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 190,820 $ (1,794) $ 105,115 $ (1,366) $ 295,935 $ (3,160) U.S. government agency securities 220,766 (2,245) 42,754 (1,286) 263,520 (3,531) Corporate debt securities 30,485 (455) 22,864 (362) 53,349 (817) Total $ 442,071 $ (4,494) $ 170,733 $ (3,014) $ 612,804 $ (7,508) The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): March 31, 2023 Amortized Cost Fair Value Due within one year $ 602,486 $ 598,941 Due after one year but within five years 206,650 205,660 Total $ 809,136 $ 804,601 Accrued interest receivable of $3.2 million and $2.8 million was classified in prepaid expenses and other current assets in the condensed consolidated balance sheet as of March 31, 2023 and December 31, 2022, respectively. In addition to available-for-sale debt securities, marketable securities also include term bond mutual funds, which are measured at fair value. As of March 31, 2023 and December 31, 2022, the fair value of the term bond mutual funds was $1.5 million. The change in fair value of the term bond mutual funds is recorded in interest and other income, net in the condensed consolidated statements of operations. The realized and unrealized gains recognized in the condensed consolidated statements of operations for the term bond mutual funds were not material during the three months ended March 31, 2023 and 2022.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	4. Fair Value Measurements The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable. Money market funds and U.S. treasury securities are classified within Level 1 because they are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Other debt securities and investments are classified within Level 2 if the investments are valued using model driven valuations which use observable inputs such as quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Available-for-sale debt securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. The Company did not have any assets or liabilities subject to fair value remeasurement on a nonrecurring basis as of March 31, 2023 and December 31, 2022. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 155,266 $ — $ 155,266 U.S. treasury securities 37,806 — 37,806 U.S. government agency securities — 48,814 48,814 Corporate debt securities — 10,474 10,474 Marketable securities: U.S. treasury securities 345,040 — 345,040 U.S. government agency securities — 373,547 373,547 Corporate debt securities — 86,014 86,014 Term bond mutual funds — 1,521 1,521 Total financial assets $ 538,112 $ 520,370 $ 1,058,482 December 31, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 219,512 $ — $ 219,512 U.S. treasury securities 13,915 — 13,915 U.S. government agency securities — 10,419 10,419 Corporate debt securities — 1,996 1,996 Marketable securities: U.S. treasury securities 438,785 — 438,785 U.S. government agency securities — 297,513 297,513 Corporate debt securities — 105,619 105,619 Term bond mutual funds — 1,488 1,488 Total financial assets $ 672,212 $ 417,035 $ 1,089,247

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	5. Balance Sheet Components Property and Equipment, net The following table summarizes property and equipment, net as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 December 31, 2022 Computers $ 16,499 $ 16,552 Capitalized internal-use software 22,769 20,230 Office equipment 3,881 3,744 Furniture and fixtures 8,879 8,881 Motor vehicles 1,140 1,158 Leasehold improvements 5,654 5,654 Construction in progress 158 224 Total property and equipment 58,980 56,443 Less: accumulated depreciation and amortization (34,766) (32,304) Property and equipment, net $ 24,214 $ 24,139 Capitalization of costs associated with internal-use software were $2.5 million and $1.3 million for the three months ended March 31, 2023 and 2022, respectively. Amortization expense of capitalized internal-use software was $1.1 million and $0.7 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023 and December 31, 2022, the net carrying value of capitalized internal-use software was $12.6 million and $11.2 million, respectively. Depreciation expense was $1.7 million for each of the three month periods ended March 31, 2023 and 2022. Accrued Liabilities The following table summarizes accrued liabilities as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 December 31, 2022 Accrued compensation $ 18,721 $ 20,192 Accrued third-party cloud infrastructure expenses 2,459 2,752 Accrued reseller commissions 6,973 7,731 Accrued advertising and marketing expenses 4,557 4,465 Advanced payments from customers 3,928 3,480 Accrued taxes 6,372 7,730 Operating lease liabilities, current 7,266 6,775 Contributions withheld for employee stock purchase plan 3,836 1,546 Other accrued expenses 4,215 4,337 Total accrued liabilities $ 58,327 $ 59,008 Noncurrent liabilities include $23.4 million and $23.3 million of long term accrued compensation as of March 31, 2023 and December 31, 2022, respectively.

Leases

Leases	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Leases	6. Leases The Company has operating leases primarily for office space. The leases have remaining lease terms of one The following table presents various components of the lease costs (in thousands): Operating Leases Three Months Ended March 31, 2023 2022 Operating lease cost $ 2,494 $ 1,775 Short-term lease cost 174 315 Variable lease cost 785 669 The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate March 31, 2023 March 31, 2022 Weighted-average remaining lease term (in years) 4.6 5.6 Weighted-average discount rate 7.8 % 7.7 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Three Months Ended March 31, Supplemental Cash Flow Information: 2023 2022 Cash payments included in the measurement of operating lease liabilities $ 2,326 $ 2,724 Operating ROU assets obtained in exchange for lease obligations — 5,324 As of March 31, 2023, maturities of the operating lease liabilities are as follows (in thousands): Operating Leases Remainder of 2023 $ 6,907 2024 9,761 2025 8,795 2026 5,533 2027 4,235 Thereafter 5,800 Total lease payments 41,032 Less: imputed interest (7,583) Present value of operating lease liabilities $ 33,449

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	7. Commitments and Contingencies Other Contractual Commitments The Company's other contractual commitments primarily consist of third-party cloud infrastructure agreements and service subscription purchase arrangements used to support operations at the enterprise level. As of March 31, 2023, other contractual commitments totaling $93.0 million remain outstanding under these agreements through 2025. Litigation and Loss Contingencies On November 1, 2022, a purported Company stockholder filed a securities class action complaint in the U.S. District Court for the Northern District of California against the Company, certain of its current officers and directors, and underwriters of the Company's initial public offering (IPO). On April 14, 2023, the court appointed lead plaintiff filed a consolidated amended class action complaint. The complaint alleges that defendants violated Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 by making material misstatements or omissions in offering documents filed in connection with the IPO. The complaint seeks unspecified damages, interest, fees, costs, and rescission on behalf of purchasers and/or acquirers of common stock issued in the IPO. The Company and the other defendants intend to vigorously defend against the claims in this action. On March 20, 2023, a purported stockholder derivative complaint was filed in the U.S. District Court for the Northern District of California. The complaint names as defendants the Company’s current directors, as well as the Company as nominal defendant, and asserts state and federal claims based on some of the same alleged misstatements as the securities class action complaint. The derivative complaint seeks unspecified damages, attorneys’ fees, and other costs. The Company and the other defendants intend to vigorously defend against the claims in this action. From time to time, the Company has been and may be in the future subject to other legal proceedings, claims, investigations, and government inquiries (collectively, Legal Proceedings) in the ordinary course of business. It has received and may receive claims from third parties asserting, among other things, infringement of their intellectual property rights, defamation, labor and employment rights, privacy, and contractual rights. There are no currently pending legal proceedings that the Company believes will have a material adverse impact on the business or condensed consolidated financial statements. Indemnifications In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to customers, business partners, and other parties with respect to certain matters, including losses arising out of intellectual property infringement claims made by third parties, if the Company has violated applicable laws, if the Company is negligent or commits acts of willful misconduct, and other liabilities with respect to its products and services and its business. In these circumstances, payment is typically conditional on the other party making a claim pursuant to the procedures specified in the particular contract. The Company also indemnifies certain of its officers, directors and certain key employees while they are serving in good faith in their respective capacities. To date, the Company has not incurred any material costs as a result of such indemnifications and has not accrued any liabilities related to such obligations in its condensed consolidated financial statements.

Stockholders' Equity and Stock

Stockholders' Equity and Stock Based Compensation	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Stockholders' Equity and Stock-Based Compensation	8. Stockholders' Equity and Stock-Based Compensation Equity Compensation Plans In August 2021, the board of directors (the Board) adopted the 2021 Equity Incentive Plan (the 2021 Plan) and the 2021 Employee Stock Purchase Plan (ESPP), effective upon the IPO. Pursuant to the 2021 Plan, the Board may grant incentive stock options to purchase shares of the Company’s common stock, non-statutory stock options to purchase shares of the Company’s common stock, stock appreciation rights, restricted stock, RSUs, performance awards (PRSUs) and other awards. The ESPP enables eligible employees to purchase shares of the Company's Class A common stock. Both the 2021 Plan and ESPP include an automatic increase to their shares reserve on January 1 of each year as set forth in the respective plan documents. In August 2022, the Board adopted the 2022 Inducement Plan (the Inducement Plan) in accordance with Listing Rule 5635(c)(4) of the Nasdaq Stock Market. Under the Inducement Plan, nonstatutory stock options, stock appreciation rights, restricted stock, RSUs, PRSUs and other awards may be granted as an inducement material for eligible persons to enter into employment with the Company. Shares of common stock reserved for future issuance were as follows (in thousands): March 31, 2023 2011 Stock Plan: Options, RSUs and PRSUs outstanding 19,180 2021 Equity Incentive Plan: Options and RSUs outstanding 10,747 Shares reserved for future award issuances 66,768 2022 Inducement Plan: Options and RSUs outstanding 3,509 Shares reserved for future award issuances 6,491 2021 Employee Stock Purchase Plan 11,181 Total shares of common stock reserved for issuance 117,876 2021 Employee Stock Purchase Plan Under the ESPP, the price at which common stock is purchased is equal to 85% of the fair market value of a share of the Company’s common stock on the first day of the offering period or the applicable purchase date, whichever is lower. The fair market value of common stock will generally be the closing sales price on the determination date. The ESPP provides an offering period of 24 months, with four purchase periods that are generally six months long and end on May 15 and November 15 of each year, except for the first purchase period, which began upon the completion of the IPO in September 2021 and ended on May 13, 2022. The ESPP also includes a reset provision for the purchase price if the fair market value of a share of the Company's common stock on the first day of any purchase period is less than or equal to the fair market value of a share of the Company's common stock on the first day of an ongoing offering. If the reset provision is triggered, a new 24-month offering period begins. The reset provision under the ESPP was triggered on May 16, 2022, and again on November 16, 2022. Each triggering of the reset provision was considered a modification in accordance with ASC 718, Stock Based Compensation , with the modification charge recognized on a straight-line basis over the new offering period. The modification did not have a material effect on the Company's stock-based compensation expense during the three months ended March 31, 2023. During the three months ended March 31, 2023 and 2022, the Company recognized $2.0 million and $3.2 million of stock-based compensation expense related to the ESPP, respectively. Stock Options Stock options are generally granted with an exercise price equal to the stock’s fair market value at the date of grant, have a 10-year contractual term, and vest over a four-year period. Share Information: Number of Shares (in thousands) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) (1) Balance as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Stock options exercised (19) $ 0.31 Stock options cancelled / forfeited / expired (3) $ 0.16 Balance as of March 31, 2023 2,736 $ 9.12 7.1 $ 17,062 Options vested and expected to vest as of March 31, 2023 2,736 $ 9.12 7.1 $ 17,062 Options exercisable as of March 31, 2023 920 $ 0.27 2.4 $ 13,884 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested. Restricted Stock Units RSUs are granted at fair market value at the date of the grant and vest over a four-year period. RSU activity, which includes PRSUs, during the three months ended March 31, 2023 is as follows: Share Information: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands, except per share data) Unvested, as of December 31, 2022 32,253 $ 18.86 Granted 1,540 $ 14.54 Vested (1) (2,261) $ 17.23 Forfeited (832) $ 17.39 Unvested, as of March 31, 2023 30,700 $ 18.80 (1) During the three months ended March 31, 2023, total shares that vested were 2.3 million, of which 0.8 million were withheld for tax purposes. The total fair value of vested RSUs during the three months ended March 31, 2023 and 2022 was $39.0 million and $106.6 million, respectively. Performance-Based Awards In May 2019, the Board approved a grant of 166,390 shares of PRSUs to the Company’s Chief Executive Officer (CEO). The vesting of these PRSUs is contingent upon the satisfaction of certain milestones. The revenue-related milestone and the liquidity event condition were met prior to December 31, 2021. As of March 31, 2023, the time-based vesting was the only condition yet to be satisfied over the remaining requisite service period, and the number of shares to vest subject to this condition is insignificant. In September 2021, the Board approved a grant of 6,000,000 PRSUs to the Company's CEO with a time-based service condition beginning January 1, 2022, and a market condition involving five separate stock price targets ranging from $70.00 to $200.00 per share for each of the five vesting tranches (CEO Performance Award). These stock price targets will be measured based on the average closing price over a consecutive 60-trading day period, beginning on the first trading day after the expiration of the final lock-up period in February 2022. The vesting of the CEO Performance Award is contingent upon the completion of the requisite service through January 1, 2029 and the achievement of the specified stock price target in each tranche on or before January 1, 2029. The stock price targets are not required to be achieved within the service period of each tranche, and accordingly, multiple tranches can vest at the same date if the specified stock price targets are achieved after December 31, 2025. The CEO Performance Award had a total grant date fair value of $131.0 million. The fair value of the CEO Performance Award was determined at grant date by using the Monte Carlo simulation model, which requires certain complex valuation assumption inputs such as measurement period, expected stock price volatility, risk-free interest rate and dividend yield. The Company recognized stock-based compensation expense associated with PRSUs granted to the CEO of $6.9 million and $6.9 million for the three months ended March 31, 2023 and 2022, respectively. These expenses were recorded in general and administrative expenses in the condensed consolidated statements of operations. Stock-Based Compensation Total stock-based compensation expense recorded for the three months ended March 31, 2023 and 2022 was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue $ 1,696 $ 1,526 Research and development 8,979 8,309 Sales and marketing (1) 15,756 12,536 General and administrative (2) 24,263 24,254 Stock-based compensation, net of amounts capitalized 50,694 46,625 Capitalized stock-based compensation 514 — Total stock-based compensation expense $ 51,208 $ 46,625 (1) Sales and marketing expense for the three months ended March 31, 2023 includes $2.4 million of stock-based compensation expense related to RSUs, options and ESPP purchase rights granted to the President of the Company. (2) General and administrative expense includes $13.8 million and $13.8 million of stock-based compensation expense associated with RSUs and PRSUs primarily granted to the CEO in September 2021 for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): March 31, 2023 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense RSUs and PRSUs $ 491,190 2.9 Stock options 12,834 3.4 ESPP 10,027 1.0 Total unrecognized stock-based compensation expense $ 514,051

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	9. Net Loss Per Share Basic net loss per share attributable to common stockholders is computed by dividing the net loss by the number of weighted-average outstanding common shares. Diluted net loss per share attributable to common stockholders is determined by giving effect to all potential common equivalents during the reporting period, unless including them yields an antidilutive result. The Company considers its stock options and RSUs as potential common stock equivalents, but excluded them from the computation of diluted net loss per share attributable to common stockholders for the three months ended March 31, 2023 and 2022, as their effect was antidilutive. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders, are the same for both Class A and Class B common stock on both an individual and combined basis. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended March 31, 2023 2022 Numerator: Net loss $ (42,664) $ (49,059) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 290,133 278,186 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.15) $ (0.18) The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Three Months Ended March 31, 2023 2022 RSUs and PRSUs 30,700 32,238 Stock options 2,736 1,236 ESPP 294 409 Total 33,730 33,883

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The Company's quarterly tax provision and estimates of its annual effective tax rate are estimates due to several factors, including changes in pre-tax income (or loss), the mix of jurisdictions to which such income relates, discrete items (such as windfalls or shortfalls from stock-based compensation) in the period offset with our valuation allowance. The provision for income taxes was $4.0 million

Geographic Information

Geographic Information	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Geographic Information	11. Geographic Information The following table summarizes revenue by geographic location (in thousands): Three Months Ended March 31, 2023 2022 North America $ 61,067 $ 48,773 Europe, Middle East and Africa 52,866 45,505 Asia Pacific 20,025 17,479 Other 3,734 2,880 Total revenue $ 137,692 $ 114,637 Revenue from North America consists primarily of revenue from the United States. For the three months ended March 31, 2023 and 2022, revenue generated from the United States was $53.9 million and $42.8 million, or 39% and 37% of total consolidated revenue, respectively. The United Kingdom, included within Europe, Middle East and Africa in the table above, contributed $17.1 million and $14.9 million or 12% and 13% of total consolidated revenue for the three months ended March 31, 2023 and 2022, respectively. Long-lived assets consist primarily of property, plant and equipment and ROU assets. The following table summarizes long-lived assets by geographic information (in thousands): March 31, 2023 December 31, 2022 North America $ 24,329 $ 23,839 Europe, Middle East and Africa 3,584 4,039 Asia Pacific 27,476 29,285 Total long-lived assets $ 55,389 $ 57,163 Long-lived assets in North America are primarily located in the United States, and long lived assets in Asia Pacific are primarily located in India.

Business, Basis of Presentati_2

Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation.
Unaudited Interim Consolidated Financial Statements	The accompanying condensed consolidated balance sheet as of March 31, 2023, the condensed consolidated statements of operations, of comprehensive loss, of cash flows, and of stockholders’ equity for the three months ended March 31, 2023 and 2022, and the related notes to such condensed consolidated financial statements are unaudited. These unaudited condensed consolidated financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of March 31, 2023 and its results of operations and cash flows for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 23, 2023.
Use of Estimates	The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of acquired intangible assets and goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases.
Concentrations of Risk	Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash, cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the three months ended March 31, 2023 and 2022 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of March 31, 2023. The Company primarily relies upon its third-party cloud infrastructure partner, Amazon Web Services, to serve customers and operate certain aspects of its services. Any disruption of this cloud infrastructure partner would impact the Company's operations and its business could be adversely impacted.
Derivative Instruments	The Company enters into foreign currency forward contracts, most of which were designated as cash flow hedges, in order to manage the volatility of cash flows that relate to cost of revenues and operating expenses denominated in Indian Rupee. All derivative instruments are measured at fair value based upon quoted market prices for comparable instruments and as such, classified within Level 2 of the fair value hierarchy. Derivative assets and liabilities are presented on a gross basis on the condensed consolidated balance sheets under prepaid expenses and other current assets and accrued liabilities, respectively. Gains or losses related to cash flow hedges are recorded as a component of accumulated other comprehensive income (AOCI) on the condensed consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within interest and other income. Changes in the fair value of currency forward exchange contracts due to changes in time value were excluded from the assessment of effectiveness. The initial value of this excluded component is amortized on a straight-line basis over the life of the hedging instrument and recognized in the f inancial statement line item to which the hedge relates. A majority of the balance related to foreign exchange derivative instruments included in AOCI at March 31, 2023 is expected to be reclassified into earnings within 12 months. Derivative instruments are classified in the condensed consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions. The Company does not use derivative financial instruments for trading or speculative purposes. As of March 31, 2023, the total notional amount of outstanding designated foreign currency forward contracts was $22.3 million. The fair value of derivative assets and liabilities as of March 31, 2023, and all related unrealized and realized gains and losses during the three months ended March 31, 2023 were not material. Entering into derivative instruments exposes the Company to credit risk to the extent that the counterparties are unable to meet the terms of the contract. The Company mitigates this credit risk by transacting with major financial institutions with high credit ratings. In addition, the Company has entered into master netting arrangements that mitigates credit risk by permitting net settlement of transactions. As such, the Company's exposure is not considered significant. The Company does not have any collateral requirements with its counterparties.
Recent Accounting Pronouncements	There have been no recently issued accounting pronouncements that are expected to have a material impact on the Company's condensed consolidated financial statements.
Revenue	The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes.
Fair Value Measurements	The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable.

Revenue From Contracts with C_2

Revenue From Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenues	The following table summarizes revenue by the Company’s service offerings (in thousands): Three Months Ended March 31, 2023 2022 Subscription services $ 134,023 $ 111,397 Professional services 3,669 3,240 Total revenue $ 137,692 $ 114,637
Summary of Changes in the Balance of Deferred Contract Acquisition Costs	The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Three Months Ended March 31, 2023 2022 Balance at beginning of the period $ 39,675 $ 29,647 Add: Contract costs capitalized during the period 5,568 5,600 Less: Amortization of contract costs during the period (5,617) (4,275) Balance at end of the period $ 39,626 $ 30,972

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-sale Securities Reconciliation	Cash equivalents and available-for-sale debt securities consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 155,266 $ — $ — $ 155,266 U.S. treasury securities 37,797 9 — 37,806 U.S. government agency securities 48,796 18 — 48,814 Corporate debt securities 10,474 — — 10,474 Total cash equivalents 252,333 27 — 252,360 Debt securities: U.S. treasury securities 346,566 95 (1,621) 345,040 U.S. government agency securities 376,006 232 (2,691) 373,547 Corporate debt securities 86,564 — (550) 86,014 Total debt securities 809,136 327 (4,862) 804,601 Total cash equivalents and debt securities $ 1,061,469 $ 354 $ (4,862) $ 1,056,961 December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 219,512 $ — $ — $ 219,512 U.S. treasury securities 13,912 3 — 13,915 U.S. government agency securities 10,417 2 — 10,419 Corporate debt securities 1,995 1 — 1,996 Total cash equivalents 245,836 6 — 245,842 Debt securities: U.S. treasury securities 441,909 36 (3,160) 438,785 U.S. government agency securities 301,009 35 (3,531) 297,513 Corporate debt securities 106,436 — (817) 105,619 Total debt securities 849,354 71 (7,508) 841,917 Total cash equivalents and debt securities $ 1,095,190 $ 77 $ (7,508) $ 1,087,759
Schedule of Available-for-Sale, Unrealized Loss Position, Fair Value	The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 89,652 $ (687) $ 76,712 $ (934) $ 166,364 $ (1,621) U.S. government agency securities 241,211 (1,701) 39,039 (990) 280,250 (2,691) Corporate debt securities 20,555 (275) 20,596 (275) 41,151 (550) Total $ 351,418 $ (2,663) $ 136,347 $ (2,199) $ 487,765 $ (4,862) December 31, 2022 Less Than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 190,820 $ (1,794) $ 105,115 $ (1,366) $ 295,935 $ (3,160) U.S. government agency securities 220,766 (2,245) 42,754 (1,286) 263,520 (3,531) Corporate debt securities 30,485 (455) 22,864 (362) 53,349 (817) Total $ 442,071 $ (4,494) $ 170,733 $ (3,014) $ 612,804 $ (7,508)
Schedule of Amortized Costs and Fair Value of Debt Securities Based on Contractual Maturities	The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): March 31, 2023 Amortized Cost Fair Value Due within one year $ 602,486 $ 598,941 Due after one year but within five years 206,650 205,660 Total $ 809,136 $ 804,601

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 155,266 $ — $ 155,266 U.S. treasury securities 37,806 — 37,806 U.S. government agency securities — 48,814 48,814 Corporate debt securities — 10,474 10,474 Marketable securities: U.S. treasury securities 345,040 — 345,040 U.S. government agency securities — 373,547 373,547 Corporate debt securities — 86,014 86,014 Term bond mutual funds — 1,521 1,521 Total financial assets $ 538,112 $ 520,370 $ 1,058,482 December 31, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 219,512 $ — $ 219,512 U.S. treasury securities 13,915 — 13,915 U.S. government agency securities — 10,419 10,419 Corporate debt securities — 1,996 1,996 Marketable securities: U.S. treasury securities 438,785 — 438,785 U.S. government agency securities — 297,513 297,513 Corporate debt securities — 105,619 105,619 Term bond mutual funds — 1,488 1,488 Total financial assets $ 672,212 $ 417,035 $ 1,089,247

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property, Plant and Equipment	The following table summarizes property and equipment, net as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 December 31, 2022 Computers $ 16,499 $ 16,552 Capitalized internal-use software 22,769 20,230 Office equipment 3,881 3,744 Furniture and fixtures 8,879 8,881 Motor vehicles 1,140 1,158 Leasehold improvements 5,654 5,654 Construction in progress 158 224 Total property and equipment 58,980 56,443 Less: accumulated depreciation and amortization (34,766) (32,304) Property and equipment, net $ 24,214 $ 24,139
Schedule of Accrued Liabilities	Accrued Liabilities The following table summarizes accrued liabilities as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 December 31, 2022 Accrued compensation $ 18,721 $ 20,192 Accrued third-party cloud infrastructure expenses 2,459 2,752 Accrued reseller commissions 6,973 7,731 Accrued advertising and marketing expenses 4,557 4,465 Advanced payments from customers 3,928 3,480 Accrued taxes 6,372 7,730 Operating lease liabilities, current 7,266 6,775 Contributions withheld for employee stock purchase plan 3,836 1,546 Other accrued expenses 4,215 4,337 Total accrued liabilities $ 58,327 $ 59,008

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Lease, Cost	The following table presents various components of the lease costs (in thousands): Operating Leases Three Months Ended March 31, 2023 2022 Operating lease cost $ 2,494 $ 1,775 Short-term lease cost 174 315 Variable lease cost 785 669 The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate March 31, 2023 March 31, 2022 Weighted-average remaining lease term (in years) 4.6 5.6 Weighted-average discount rate 7.8 % 7.7 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Three Months Ended March 31, Supplemental Cash Flow Information: 2023 2022 Cash payments included in the measurement of operating lease liabilities $ 2,326 $ 2,724 Operating ROU assets obtained in exchange for lease obligations — 5,324
Lessee, Operating Lease, Liability, Maturity	As of March 31, 2023, maturities of the operating lease liabilities are as follows (in thousands): Operating Leases Remainder of 2023 $ 6,907 2024 9,761 2025 8,795 2026 5,533 2027 4,235 Thereafter 5,800 Total lease payments 41,032 Less: imputed interest (7,583) Present value of operating lease liabilities $ 33,449

Stockholders' Equity and Stoc_2

Stockholders' Equity and Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Summary of Common Shares Reserved for Future Issuance	Shares of common stock reserved for future issuance were as follows (in thousands): March 31, 2023 2011 Stock Plan: Options, RSUs and PRSUs outstanding 19,180 2021 Equity Incentive Plan: Options and RSUs outstanding 10,747 Shares reserved for future award issuances 66,768 2022 Inducement Plan: Options and RSUs outstanding 3,509 Shares reserved for future award issuances 6,491 2021 Employee Stock Purchase Plan 11,181 Total shares of common stock reserved for issuance 117,876
Schedule of Stock Option Activity	Share Information: Number of Shares (in thousands) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) (1) Balance as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Stock options exercised (19) $ 0.31 Stock options cancelled / forfeited / expired (3) $ 0.16 Balance as of March 31, 2023 2,736 $ 9.12 7.1 $ 17,062 Options vested and expected to vest as of March 31, 2023 2,736 $ 9.12 7.1 $ 17,062 Options exercisable as of March 31, 2023 920 $ 0.27 2.4 $ 13,884 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested.
Schedule of Restricted Stock Unit Activity	RSU activity, which includes PRSUs, during the three months ended March 31, 2023 is as follows: Share Information: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands, except per share data) Unvested, as of December 31, 2022 32,253 $ 18.86 Granted 1,540 $ 14.54 Vested (1) (2,261) $ 17.23 Forfeited (832) $ 17.39 Unvested, as of March 31, 2023 30,700 $ 18.80 (1) During the three months ended March 31, 2023, total shares that vested were 2.3 million, of which 0.8 million were withheld for tax purposes.
Stock-based Compensation Expense	Total stock-based compensation expense recorded for the three months ended March 31, 2023 and 2022 was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue $ 1,696 $ 1,526 Research and development 8,979 8,309 Sales and marketing (1) 15,756 12,536 General and administrative (2) 24,263 24,254 Stock-based compensation, net of amounts capitalized 50,694 46,625 Capitalized stock-based compensation 514 — Total stock-based compensation expense $ 51,208 $ 46,625 (1) Sales and marketing expense for the three months ended March 31, 2023 includes $2.4 million of stock-based compensation expense related to RSUs, options and ESPP purchase rights granted to the President of the Company. (2) General and administrative expense includes $13.8 million and $13.8 million of stock-based compensation expense associated with RSUs and PRSUs primarily granted to the CEO in September 2021 for the three months ended March 31, 2023 and 2022, respectively.
Share-based Payment Arrangement, Nonvested Award, Cost	As of March 31, 2023, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): March 31, 2023 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense RSUs and PRSUs $ 491,190 2.9 Stock options 12,834 3.4 ESPP 10,027 1.0 Total unrecognized stock-based compensation expense $ 514,051

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended March 31, 2023 2022 Numerator: Net loss $ (42,664) $ (49,059) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 290,133 278,186 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.15) $ (0.18)
Schedule of Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share	The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Three Months Ended March 31, 2023 2022 RSUs and PRSUs 30,700 32,238 Stock options 2,736 1,236 ESPP 294 409 Total 33,730 33,883

Geographic Information (Tables)

Geographic Information (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of Revenue and Long-Lived Assets by Geographical Region	The following table summarizes revenue by geographic location (in thousands): Three Months Ended March 31, 2023 2022 North America $ 61,067 $ 48,773 Europe, Middle East and Africa 52,866 45,505 Asia Pacific 20,025 17,479 Other 3,734 2,880 Total revenue $ 137,692 $ 114,637 March 31, 2023 December 31, 2022 North America $ 24,329 $ 23,839 Europe, Middle East and Africa 3,584 4,039 Asia Pacific 27,476 29,285 Total long-lived assets $ 55,389 $ 57,163

Business, Basis of Presentati_3

Business, Basis of Presentation and Summary of Significant Accounting Policies (Details) $ in Millions	Mar. 31, 2023 USD ($)
Foreign Exchange Forward
Derivative [Line Items]
Notional amount	$ 22.3

Revenue From Contracts with C_3

Revenue From Contracts with Customers - Disaggregation of Revenues (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 137,692	$ 114,637
Subscription services
Disaggregation of Revenue [Line Items]
Revenue	134,023	111,397
Professional services
Disaggregation of Revenue [Line Items]
Revenue	$ 3,669	$ 3,240

Revenue From Contracts with C_4

Revenue From Contracts with Customers - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized during the period	$ 93.7	$ 72.2
Remaining performance obligation	325.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 253.7
Remaining performance obligation, expected timing of satisfaction, period	12 months

Revenue From Contracts with C_5

Revenue From Contracts with Customers - Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Change in Deferred Contract Acquisition Costs [Roll Forward]
Balance at beginning of the period	$ 39,675	$ 29,647
Add: Contract costs capitalized during the period	5,568	5,600
Less: Amortization of contract costs during the period	(5,617)	(4,275)
Balance at end of the period	$ 39,626	$ 30,972

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Schedule of Carrying Amounts and Fair Values of Debt Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Unrealized Gains	$ 354	$ 77
Unrealized Losses	(4,862)	(7,508)
Cash Equivalents and Available-for-sale Debt Securities
Amortized Cost	1,061,469	1,095,190
Fair Value	1,056,961	1,087,759
Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Unrealized Gains	27	6
Unrealized Losses	0	0
Cash Equivalents and Available-for-sale Debt Securities
Amortized Cost	252,333	245,836
Fair Value	252,360	245,842
Cash Equivalents | U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	37,797	13,912
Unrealized Gains	9	3
Unrealized Losses	0	0
Fair Value	37,806	13,915
Cash Equivalents | U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	48,796	10,417
Unrealized Gains	18	2
Unrealized Losses	0	0
Fair Value	48,814	10,419
Cash Equivalents | Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	10,474	1,995
Unrealized Gains	0	1
Unrealized Losses	0	0
Fair Value	10,474	1,996
Marketable Securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	809,136	849,354
Unrealized Gains	327	71
Unrealized Losses	(4,862)	(7,508)
Fair Value	804,601	841,917
Marketable Securities | U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	346,566	441,909
Unrealized Gains	95	36
Unrealized Losses	(1,621)	(3,160)
Fair Value	345,040	438,785
Marketable Securities | U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	376,006	301,009
Unrealized Gains	232	35
Unrealized Losses	(2,691)	(3,531)
Fair Value	373,547	297,513
Marketable Securities | Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	86,564	106,436
Unrealized Gains	0	0
Unrealized Losses	(550)	(817)
Fair Value	86,014	105,619
Money market funds
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents	$ 155,266	$ 219,512

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Schedule of Continuous Unrealized Loss Position and Fair Values of Debt Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value
Less than 12 months	$ 351,418	$ 442,071
Greater than 12 months	136,347	170,733
Total	487,765	612,804
Unrealized Loss
Less than 12 months	(2,663)	(4,494)
Greater than 12 months	(2,199)	(3,014)
Total	(4,862)	(7,508)
U.S. treasury securities
Fair Value
Less than 12 months	89,652	190,820
Greater than 12 months	76,712	105,115
Total	166,364	295,935
Unrealized Loss
Less than 12 months	(687)	(1,794)
Greater than 12 months	(934)	(1,366)
Total	(1,621)	(3,160)
U.S. government agency securities
Fair Value
Less than 12 months	241,211	220,766
Greater than 12 months	39,039	42,754
Total	280,250	263,520
Unrealized Loss
Less than 12 months	(1,701)	(2,245)
Greater than 12 months	(990)	(1,286)
Total	(2,691)	(3,531)
Corporate debt securities
Fair Value
Less than 12 months	20,555	30,485
Greater than 12 months	20,596	22,864
Total	41,151	53,349
Unrealized Loss
Less than 12 months	(275)	(455)
Greater than 12 months	(275)	(362)
Total	$ (550)	$ (817)

Cash Equivalents and Marketab_5

Cash Equivalents and Marketable Securities - Amortized Cost and Fair Value Based on Contractual Maturities (Details) - Marketable Securities - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Amortized Cost
Due within one year	$ 602,486
Due after one year but within five years	206,650
Debt securities, Amortized Cost	809,136	$ 849,354
Fair Value
Due within one year	598,941
Due after one year but within five years	205,660
Total	$ 804,601	$ 841,917

Cash Equivalents and Marketab_6

Cash Equivalents and Marketable Securities - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Accrued interest	$ 3.2	$ 2.8
Mutual funds
Debt Securities, Available-for-sale [Line Items]
Equity securities	$ 1.5	$ 1.5

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	$ 1,058,482	$ 1,089,247
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	345,040	438,785
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	373,547	297,513
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	86,014	105,619
Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,521	1,488
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	155,266	219,512
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	37,806	13,915
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	48,814	10,419
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	10,474	1,996
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	538,112	672,212
Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	345,040	438,785
Level 1 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	155,266	219,512
Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	37,806	13,915
Level 1 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	520,370	417,035
Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	373,547	297,513
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	86,014	105,619
Level 2 | Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,521	1,488
Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	48,814	10,419
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	$ 10,474	$ 1,996

Balance Sheet Components - Prop

Balance Sheet Components - Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 58,980	$ 56,443
Less: accumulated depreciation and amortization	(34,766)	(32,304)
Property and equipment, net	24,214	24,139
Computers
Property, Plant and Equipment [Line Items]
Total property and equipment	16,499	16,552
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment	22,769	20,230
Office equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	3,881	3,744
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	8,879	8,881
Motor vehicles
Property, Plant and Equipment [Line Items]
Total property and equipment	1,140	1,158
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	5,654	5,654
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 158	$ 224

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized costs	$ 2.5	$ 1.3
Amortization expense	1.1	0.7
Net carrying value	12.6		$ 11.2
Depreciation expense and amortization	1.7	$ 1.7
Long-term accrued compensation	$ 23.4		$ 23.3

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation	$ 18,721	$ 20,192
Accrued third-party cloud infrastructure expenses	2,459	2,752
Accrued reseller commissions	6,973	7,731
Accrued advertising and marketing expenses	4,557	4,465
Advanced payments from customers	3,928	3,480
Accrued taxes	6,372	7,730
Operating lease liabilities, current	7,266	6,775
Contributions withheld for employee stock purchase plan	3,836	1,546
Other accrued expenses	4,215	4,337
Accrued liabilities	$ 58,327	$ 59,008

Leases - Narrative (Details)

Leases - Narrative (Details)	Mar. 31, 2023
Lessee, Lease, Description [Line Items]
Operating lease, option to extend, term	6 years
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, term	8 years

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating lease cost	$ 2,494	$ 1,775
Short-term lease cost	174	315
Variable lease cost	$ 785	$ 669

Leases - Summary of Lease Term

Leases - Summary of Lease Term and Discount Rate (Details)	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Weighted-average remaining lease term (in years)	4 years 7 months 6 days	5 years 7 months 6 days
Weighted-average discount rate	7.80%	7.70%

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Cash payments included in the measurement of operating lease liabilities	$ 2,326	$ 2,724
Operating lease right-of-use assets obtained in exchange for operating lease obligations	$ 0	$ 5,324

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Leases [Abstract]
Remainder of 2023	$ 6,907
2024	9,761
2025	8,795
2026	5,533
2027	4,235
Thereafter	5,800
Total lease payments	41,032
Less: imputed interest	(7,583)
Present value of operating lease liabilities	$ 33,449

Commitment and Contingencies (D

Commitment and Contingencies (Details) $ in Millions	Mar. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Contractual commitments	$ 93

Stockholders' Equity and Stoc_3

Stockholders' Equity and Stock Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended
	Sep. 30, 2021 USD ($) tranche target $ / shares shares	May 31, 2019 shares	Mar. 31, 2023 USD ($) purchasePeriod shares	Mar. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expensed and capitalized, amount			$ 51,208	$ 46,625
Stock-based compensation, net of amounts capitalized			$ 50,694	46,625
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock in percent			85%
Offering period			24 months
Number of purchase periods | purchasePeriod			4
Purchase period			6 months
ESPP offering period			24 months
Share-based payment arrangement, expensed and capitalized, amount			$ 2,000	3,200
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual term			10 years
Award vesting period			4 years
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			4 years
Total grant date fair value			$ 39,000	106,600
Granted (in shares) | shares			1,540,000
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total grant date fair value	$ 131,000
Granted (in shares) | shares	6,000,000	166,390
Number of threshold stock price targets | target	5
Number of threshold vesting tranches | tranche	5
Trading day period	60 days
Stock-based compensation, net of amounts capitalized			$ 6,900	$ 6,900
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold stock price target (in USD per share) | $ / shares	$ 70
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold stock price target (in USD per share) | $ / shares	$ 200

Stockholders' Equity and Stoc_4

Stockholders' Equity and Stock Based Compensation - Shares of Common Stock Reserved for Future Issuance (Details) shares in Thousands	Mar. 31, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	117,876
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	11,181
2011 Stock Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	19,180
2021 Equity Incentive Plan:
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	66,768
2021 Equity Incentive Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	10,747
2022 Inducement Plan:
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	6,491
2022 Inducement Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	3,509

Stockholders' Equity and Stoc_5

Stockholders' Equity and Stock Based Compensation - Summary of Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2023	Jun. 30, 2022	Dec. 31, 2022
Number of Shares (in thousands)
Beginning balance (in shares)	2,758
Stock options exercised (in shares)	(19)
Stock options cancelled / forfeited / expired (in shares)	(3)
Ending balance (in shares)	2,736
Options vested or expected to vest (in shares)	2,736
Options exercisable (in shares)	920
Weighted-Average Exercise Price
Beginning balance (in USD per share)	$ 9.06
Stock options exercised (in USD per share)	0.31
Stock options cancelled / forfeited / expired (in USD per share)	0.16
Ending balance (in USD per share)	9.12
Options vested or expected to vest (in USD per share)	9.12
Options exercisable (in USD per share)	$ 0.27
Weighted-Average Remaining Contractual Term (in years)
Weighted-Average Remaining Contractual Term (in years)	7 years 1 month 6 days	7 years 3 months 18 days
Options vested or expected to vest as of the end of the period	7 years 1 month 6 days
Options exercisable as of the end of the period	2 years 4 months 24 days
Aggregate Intrinsic Value
Aggregate intrinsic value	$ 17,062		$ 15,595
Options vested or expected to vest as of the end of the period	17,062
Options exercisable as of the end of the period	$ 13,884

Stockholders' Equity and Stoc_6

Stockholders' Equity and Stock Based Compensation - Schedule of Restricted Stock Unit Activity (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Weighted-Average Grant Date Fair Value Per Share
Stock withheld for tax withholding requirements (in shares)	800,000
Restricted Stock Units
Number of Shares
Unvested, beginning balance (in shares)	32,253,000
Granted (in shares)	1,540,000
Vested (in shares)	(2,261,000)
Forfeited (in shares)	(832,000)
Unvested, ending balance (in shares)	30,700,000
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in USD per share) | $ / shares	$ 18.86
Granted (in USD per share) | $ / shares	14.54
Vested (in USD per share) | $ / shares	17.23
Forfeited (in USD per share) | $ / shares	17.39
Unvested, ending balance (in USD per share) | $ / shares	$ 18.80

Stockholders' Equity and Stoc_7

Stockholders' Equity and Stock Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 50,694	$ 46,625
Capitalized stock-based compensation	514	0
Total stock-based compensation expense	51,208	46,625
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	1,696	1,526
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	8,979	8,309
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	15,756	12,536
Sales and marketing | President
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	2,400
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	24,263	24,254
General and administrative | RSUs and PRSUs
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 13,800	$ 13,800

Stockholders' Equity and Stoc_8

Stockholders' Equity and Stock Based Compensation - Schedule of Unrecognized Stock-Based Compensation (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, including options	$ 12,834
Total unrecognized stock-based compensation expense	514,051
RSUs and PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, excluding options	$ 491,190
Weighted-Average Period to Recognize Expense (in years)	2 years 10 months 24 days
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Period to Recognize Expense (in years)	3 years 4 months 24 days
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, excluding options	$ 10,027
Weighted-Average Period to Recognize Expense (in years)	1 year

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net loss	$ (42,664)	$ (49,059)
Denominator:
Weighted-average shares used in computing net loss per share - basic (in shares)	290,133	278,186
Weighted-average shares used in computing net loss per share - diluted (in shares)	290,133	278,186
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share)	$ (0.15)	$ (0.18)
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share)	$ (0.15)	$ (0.18)

Net Loss Per Share - Potential

Net Loss Per Share - Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	33,730	33,883
RSUs and PRSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	30,700	32,238
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,736	1,236
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	294	409

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 4,036	$ 2,537

Geographic Information - Schedu

Geographic Information - Schedule of Revenue and Long-lived Assets by Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 137,692	$ 114,637
Total long-lived assets	55,389		$ 57,163
North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	61,067	48,773
Total long-lived assets	24,329		23,839
Europe, Middle East and Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	52,866	45,505
Total long-lived assets	3,584		4,039
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	20,025	17,479
Total long-lived assets	27,476		$ 29,285
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 3,734	$ 2,880

Geographic Information - Additi

Geographic Information - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 137,692	$ 114,637
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 53,900	$ 42,800
UNITED STATES | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk percentage	39%	37%
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 17,100	$ 14,900
UNITED KINGDOM | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk percentage	12%	13%